The American Journal of Medicine
Volume 123, Issue 7 , Pages 631-637 , July 2010

The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia

  • Hitoshi Honda, MD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo
    • Corresponding Author InformationReprint requests should be addressed to Hitoshi Honda, MD, 660 South Euclid Avenue, Campus Box 8051, St Louis, MO 63110
    • ,
  • Melissa J. Krauss, MPH

      Affiliations

    • Division of Biostatistics, Department of Medicine, Washington University School of Medicine, St Louis, Mo
    • ,
  • Jeffrey C. Jones, MD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo
    • ,
  • Margaret A. Olsen, PhD, MPH

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo
    • ,
  • David K. Warren, MD, MPH

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo

References 

  1. Fowler VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478–486
  2. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000;31:1170–1174
  3. Beeston CJ, Gupta R, Chadwick PR, Young RJ. Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital. Eur J Clin Microbiol Infect Dis. 2009;28:585–590
  4. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–155
  5. Jensen AG, Wachmann CH, Espersen F, et al. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002;162:25–32
  6. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162:2229–2235
  7. Chang FY, Peacock JE, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82:333–339
  8. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45
  9. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–e434
  10. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000–1008
  11. Roots Web. Social Security Death Index. http://ssdi.genealogy.rootsweb.com/Accessed August 30, 2009
  12. Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653–665
  13. Klevens RM, Morrison MA, Fridkin SK, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis. 2006;12:1991;-1193
  14. Andersen PK, Gill RD. Cox regression model for counting processes: a large sample study. Ann Stat. 1982;10:1100–1120
  15. Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text. Second edition. New York, NY: Springer; 2005;
  16. Schoenfeld D. Partial residuals for the proportional hazards model. Biometrika. 1982;69:51–55
  17. Snappin SM, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat. 2005;59:301–307
  18. Schisterman EF, Whitcomb BW. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr. 2004;2:2
  19. Quinn J, Kramer N, McDermott D. Validation of the Social Security Death Index (SSDI): an important readily-available outcomes database for researchers. West J Emerg Med. 2008;9:6–8
  20. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation—a study of 521 patients in Germany. J Infect. 2009;59:232–239Epub 2009 Aug 3
  21. Malani PN, Rana MM, Banerjee M, Bradley SF. Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatr Soc. 2008;56:1485–1489
  22. McClelland RS, Fowler VG, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med. 1999;159:1244–1247
  23. Kim SH, Park WB, Lee KD, et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis. 2003;37:794–799
  24. Hill PC, Birch M, Chambers S, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97–103
  25. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med. 1998;158:182–189
  26. Crowley AL, Peterson GE, Benjamin DK, et al. Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med. 2008;36:385–390
  27. Fowler VG, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695–703
  28. Rhee JY, Kwon KT, Ki HK, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009;31:146–150

 Funding: Centers for Disease Control and Prevention Epicenter (5U01CI000033302). MJK is funded by the National Center for Research Resources, a component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research (UL1 RR024992).

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00128-2

doi: 10.1016/j.amjmed.2010.01.015

The American Journal of Medicine
Volume 123, Issue 7 , Pages 631-637 , July 2010

Article Tools

* Image Usage & Resolution